Cumberland Pharmaceuticals (CPIX) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for Cumberland Pharmaceuticals (CPIX) over the last 15 years, with Q4 2024 value amounting to $4.9 million.
- Cumberland Pharmaceuticals' Accumulated Depreciation & Amortization fell 67.65% to $4.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.9 million, marking a year-over-year decrease of 67.65%. This contributed to the annual value of $4.9 million for FY2024, which is 67.65% down from last year.
- Per Cumberland Pharmaceuticals' latest filing, its Accumulated Depreciation & Amortization stood at $4.9 million for Q4 2024, which was down 67.65% from $4.9 million recorded in Q4 2023.
- In the past 5 years, Cumberland Pharmaceuticals' Accumulated Depreciation & Amortization ranged from a high of $5.3 million in Q4 2022 and a low of $4.6 million during Q4 2021
- Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $4.9 million (2024), whereas its average is $4.9 million.
- In the last 5 years, Cumberland Pharmaceuticals' Accumulated Depreciation & Amortization soared by 1566.85% in 2022 and then tumbled by 736.02% in 2023.
- Cumberland Pharmaceuticals' Accumulated Depreciation & Amortization (Quarter) stood at $4.7 million in 2020, then dropped by 2.99% to $4.6 million in 2021, then rose by 15.67% to $5.3 million in 2022, then dropped by 7.36% to $4.9 million in 2023, then dropped by 0.68% to $4.9 million in 2024.
- Its last three reported values are $4.9 million in Q4 2024, $4.9 million for Q4 2023, and $5.3 million during Q4 2022.